Retinal drug delivery using eyedrop preparations of poly-l-lysine-modified liposomes

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 83, Issue 3, 2013, Pages 364-369

  Sasaki, Hitoshi ^a   Karasawa, Keiichi ^a   Hironaka, Kohei ^a   Tahara, Kohei ^a   Tozuka, Yuichi ^a,b   Takeuchi, Hirofumi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Eye drop; Liposome; Poly l lysine; Posterior segment; Retina; Surface modification

Indexed keywords

ESCULIN; EYE DROPS; LIPOSOME; POLYLYSINE;

ANIMAL CELL; ARTICLE; CHEMICAL MODIFICATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; RETINA; SURFACE PROPERTY; TISSUE DISTRIBUTION;

ANIMALS; DRUG DELIVERY SYSTEMS; LIPOSOMES; MALE; MICE; OPHTHALMIC SOLUTIONS; POLYLYSINE; RETINA;

EID: 84875209383     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.10.014     Document Type: Article

References (23)

1. E. Margalit, and S.R. Sadda Retinal and optic nerve diseases Artif. Organs. 27 2003 963 974
2. R. Gaudana, H.K. Ananthula, A. Parenky, and A.K. Mitra Ocular drug delivery AAPS J. 12 2010 348 360
3. M.A. Eldaly, and C. Styles First versus second eye intravitreal ranibizumab therapy for wet AMD Retina 29 2009 325 328
4. S.P. Ayalasomayajula, and U.B. Kompella Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model Eur. J. Pharmacol. 511 2005 191 198
5. A. Carneiro, M. Falcao, A. Pirraco, P. Milheiro-Oliveira, F. Falcao-Reis, and R. Soares Comparative effects of bevacizumab, ranibizumab and pegaptanib at intravitreal dose range on endothelial cells Exp. Eye Res. 88 2009 522 527
6. T. Yasukawa, H. Kimura, Y. Tabata, and Y. Ogura Biodegradable scleral plugs for vitreoretinal drug delivery Adv. Drug Deliv. Rev. 52 2001 25 36
7. S.L. Law, K.J. Huang, and C.H. Chiang Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption J. Control. Release 63 2000 135 140
8. R.M. Hathout, S. Mansour, N.D. Mortada, and A.S. Guinedi Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies AAPS PharmSciTech 8 2007 E1 E12
9. I.P. Kaur, A. Garg, A.K. Singla, and D. Aggarwal Vesicular systems in ocular drug delivery: an overview Int. J. Pharm. 269 2004 1 14
10. G. Abdelbary, and N. El-Gendy Niosome-encapsulated gentamicin for ophthalmic controlled delivery AAPS PharmSciTech 9 2008 740 747
11. S.M. Agnihotri, and P.R. Vavia Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application Nanomedicine 5 2009 90 95
12. A.A. Badawi, H.M. El-Laithy, R.K. El Qidra, H. El Mofty, and M. El dally Chitosan based nanocarriers for indomethacin ocular delivery Arch. Pharm. Res. 31 2008 1040 1049
13. K. Hironaka, Y. Inokuchi, Y. Tozuka, M. Shimazawa, H. Hara, and H. Takeuchi Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye J. Control. Release 136 2009 247 253
14. H. Shimazaki, K. Hironaka, T. Fujisawa, K. Tsuruma, Y. Tozuka, M. Shimazawa, H. Takeuchi, and H. Hara Edaravone-loaded liposome eyedrops protect against light-induced retinal damage in mice Invest Ophthalmol. Vis. Sci. 52 2011 7289 7297
15. Y. Inokuchi, K. Hironaka, T. Fujisawa, Y. Tozuka, K. Tsuruma, M. Shimazawa, H. Takeuchi, and H. Hara Physicochemical properties affecting retinal drug/coumarin-6 delivery from nanocarrier systems via eyedrop administration Invest. Ophthalmol. Vis Sci. 51 2010 3162 3170
16. M. Murata, K. Nakano, K. Tahara, Y. Tozuka, and H. Takeuchi Pulmonary delivery of elcatonin using surface-modified liposomes to improve systemic absorption: polyvinyl alcohol with a hydrophobic anchor and chitosan oligosaccharide as effective surface modifiers Eur. J. Pharm. Biopharm. 80 2012 340 346
17. A. Makhlof, S. Fujimoto, Y. Tozuka, and H. Takeuchi In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery Eur. J. Pharm. Biopharm. 77 2011 216 224
18. K. Tahara, S. Furukawa, H. Yamamoto, and Y. Kawashima Hybrid-modified poly(d,l-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system Int. J. Pharm. 392 2010 311 313
19. X.Y. Yu, B.H. Schofield, T. Croxton, N. Takahashi, E.W. Gabrielson, and E.W. Spannhake Physiologic modulation of bronchial epithelial cell barrier function by polycationic exposure Am. J. Respir. Cell Mol. Biol. 11 1994 188 198
20. G.T. McEwan, M.A. Jepson, B.H. Hirst, and N.L. Simmons Polycation-induced enhancement of epithelial paracellular permeability is independent of tight junctional characteristics Biochim. Biophys. Acta 1148 1993 51 60
21. K. Araki-Sasaki, Y. Ohashi, T. Sasabe, K. Hayashi, H. Watanabe, Y. Tano, and H. Handa An SV40-immortalized human corneal epithelial cell line and its characterization Invest Ophthalmol. Vis. Sci. 36 1995 614 621
22. N. Li, C. Zhuang, M. Wang, X. Sun, S. Nie, and W. Pan Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery Int. J. Pharm. 379 2009 131 138
23. D.M. Morgan, V.L. Larvin, and J.D. Pearson Biochemical characterisation of polycation-induced cytotoxicity to human vascular endothelial cells J. Cell Sci. 94 1989 553 559